As previously reported, the TCR-dependent activation-induced marker (AIM) was used to identify and quantify virus-specific CD4+ (co-expression of OX40+CD137+) or CD8+ T (co-expression of CD69+CD137+) cells in recovered COVID-19 individuals25. This evidence concerns the gene CD8A and COVID-19.